Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

AbCellera to Present at Upcoming Investor Conferences in March


AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences:

Live audio webcasts of each presentation may be accessed through links that will be posted on AbCellera's Investor Relations website. Replays of each webcast will be available through the same links following the presentations.

About AbCellera Biologics Inc.
AbCellera is breaking the barriers of conventional antibody discovery to bring better medicines to patients, sooner. AbCellera's engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in nearly every therapeutic area with precision and speed. AbCellera provides innovative biotechs and leading pharmaceutical companies with a competitive advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.


These press releases may also interest you

at 02:10
"Bleach: Brave Souls" 9th Anniversary Bankai Live Airs Sunday, July 14 with Special Voice Actors Masakazu Morita, Ryotaro Okiayu, Kentaro Ito, and Hiroki Yasumoto Scheduled to Make an Appearance
KLab Inc., a leader in online mobile games, announced that its hit 3D action game Bleach: Brave Souls will be holding a Bleach: Brave Souls 9th Anniversary Bankai Live! on Sunday, July 14, 2024 from 18:30 (JST/UTC+9). See the original press release...

at 02:00
Azentio expands its leadership team with 2 new appointments
Azentio Software ("Azentio") - a leading end-to-end software company specializing in the BFSI sector, today announced the appointment of Aarthi Ramesh as Chief Customer Officer and Emma Foley as Chief Marketing Officer....

at 01:15
Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI: Appointment of Adviser
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

at 01:05
Bel Group and Dassault Systèmes Partner to Accelerate the Food Industry Transition Towards a More Sustainable Model
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Bel Group, today announced their long-term partnership to accelerate the food industry's transformation toward a more sustainable model. The companies will play a pivotal role in shaping...

at 01:05
Dubai Media Announces Partnership with NEP Group
Dubai Media has signed a memorandum of understanding with NEP Group, the leading media services provider supporting premier broadcasters and content creators worldwide, to enhance cooperation and exchange expertise in various media services fields....

More news about Science and technology...


News published on and distributed by: